Active Ingredient Palivizumab
Active Ingredient Details
What is Palivizumab?
A humanized monoclonal antibody and ANTIVIRAL AGENT that is used to prevent RESPIRATORY SYNCYTIAL VIRUS INFECTIONS in high risk pediatric patients.
What is the usage for Palivizumab?
Palivizumab is used in certain infants and young children to prevent serious lung infections (such as pneumonia) that are caused by a certain virus (respiratory syncytial virus-RSV). Palivizumab works by preventing the growth of the virus. This medication is not used to treat RSV infection, but should be continued even if your child gets the RSV infection to prevent a more serious infection.
How many products in the NDC database contain Palivizumab?
The NDC database has 3 products with the active ingredient Palivizumab. The following table lists all the products that have this active ingredient.
NDC Products with Palivizumab
| NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Status | |
|---|---|---|---|---|---|---|---|
| 0310-4113 | Proprietary Name: | Palivizumab | Liquid | Astrazeneca Pharmaceuticals Lp | ACTIVE | ||
| 66658-230 | Proprietary Name: Synagis | Palivizumab | Injection, Solution | Intramuscular | Swedish Orphan Biovitrum Ab (publ) | ACTIVE | |
| 66658-231 | Proprietary Name: Synagis | Palivizumab | Injection, Solution | Intramuscular | Swedish Orphan Biovitrum Ab (publ) | ACTIVE |